Skip to content

Efficacy of Shitali Respiratory Rehabilitation Program in Obstructive Sleep Apnea

Efficacy of Shitali Respiratory Rehabilitation Program in Obstructive Sleep Apnea

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06715228
Enrollment
40
Registered
2024-12-04
Start date
2024-11-07
Completion date
2025-04-15
Last updated
2024-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

obstructive sleep apnea has a negative impact on blood pressure of patients, sleeping quality, and respiration

Detailed description

in this study, patients (n=40) with obstructive sleep apnea will participate in this study to be divided in to group I and group II with an equal number of patients (n = 20 for the group). Group I will administer six cycles of 5-min shitali respiratory pranayama exercise rehabilitation training (the rehabilitation will be repeated or applied at morning, afternoon, and also at evening) for 12 week as a daily performance, the other group, Group II, will act as control group.

Interventions

BEHAVIORALshitali pranayama respiratory rehabilitation training

in this group, patients (n=20) with obstructive sleep apnea will participate and will administer six cycles of 5-min shitali respiratory pranayama exercise rehabilitation training (the rehabilitation will be repeated or applied at morning, afternoon, and also at evening) for 12 week as a daily performance

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* non-obese patients * obstructive sleep apnea (mild and moderate form)

Exclusion criteria

* cardiac patients metabolic diseases kidney diseases

Design outcomes

Primary

MeasureTime frameDescription
apnea hypopnea indexit will be assessed after 12 weeksit will be measured through a sleep study

Secondary

MeasureTime frameDescription
diastolic blood pressureit will be assessed after 12 weeksit will be assessed via a sphygmomnamoeter
Pittsburg sleep quality indexit will be assessed after 12 weeksit will assess sleep quality
systolic blood pressureit will be assessed after 12 weeksit will be assessed via a sphygmomnamoeter
Epworth sleepiness scaleit will be assessed after 12 weeksit ill assess daytime sleepiness
visual analogue scale of by-partner reported sleep difficultyit will be measured after 12 weeksit will assess by-partner reported sleep difficulty due to snoring of patient
respiratory rateit will be assessed after 12 weeksit will assess respiratory cycle per minute

Countries

Egypt

Contacts

Primary ContactAli Isamil, Lecturer
ali.mohamed@pt.cu.edu.eg0201005154209
Backup Contactahmed elfahl, Lecturer
ahmed.elfahl@buc.edu.eg0201001891218

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026